Chris Rivera is stepping down as president and CEO of the Washington Biotechnology & Biomedical Association, a nonprofit biotech trade group. He… Read More
Shares of Seattle-based biotech startup Juno Therapeutics spiked more than 60 percent in after-hours trading on Monday after the company announced… Read More
Dendreon, the once-promising Seattle biotechnology company that developed treatments for prostate cancer, will be sold to Quebec-based Valeant Pharmaceuticals International Inc.… Read More
Juno Therapeutics, the fast-growing Seattle biotechnology company, today announced that it plans to open a new manufacturing facility in Bothell… Read More
Adaptive Biotechnologies, a Seattle company that’s working on sequencing to profile T-cell and B-cell receptors, today announced that it is acquiring… Read More
Cerevast Therapeutics, a 5-year-old Redmond company that’s developing a novel approach for treating stroke patients with ultrasound, has raised $10 million… Read More
Fast-moving Juno Therapeutics is moving closer to becoming a publicly-traded company. The Seattle biotechnology company today updated is IPO filing… Read More
Seattle’s Fred Hutchinson Cancer Research Center has tapped D. Gary Gilliland, an expert in cancer genetics and former vice president of precision medicine… Read More
Immune Design Corp., a Seattle biotechnology company developing technologies to activate the body’s immune system to fight cancer, has filed… Read More
One big problem with existing cancer therapies available today like chemotherapy and radiation is the collateral damage. While some medicine… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
